Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Jan 26;290(6464):260–261. doi: 10.1136/bmj.290.6464.260

Ketoconazole: a reappraisal.

R J Hay
PMCID: PMC1417545  PMID: 3917777

Full text

PDF
261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bingham J. S. Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis. Br J Vener Dis. 1984 Jun;60(3):175–177. doi: 10.1136/sti.60.3.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DeFelice R., Johnson D. G., Galgiani J. N. Gynecomastia with ketoconazole. Antimicrob Agents Chemother. 1981 Jun;19(6):1073–1074. doi: 10.1128/aac.19.6.1073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dismukes W. E., Stamm A. M., Graybill J. R., Craven P. C., Stevens D. A., Stiller R. L., Sarosi G. A., Medoff G., Gregg C. R., Gallis H. A. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. Ann Intern Med. 1983 Jan;98(1):13–20. doi: 10.7326/0003-4819-98-1-13. [DOI] [PubMed] [Google Scholar]
  4. Drouhet E., Dupont B. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Am J Med. 1983 Jan 24;74(1B):30–47. doi: 10.1016/0002-9343(83)90512-0. [DOI] [PubMed] [Google Scholar]
  5. Gottlieb M. S., Schroff R., Schanker H. M., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10;305(24):1425–1431. doi: 10.1056/NEJM198112103052401. [DOI] [PubMed] [Google Scholar]
  6. Hann I. M., Prentice H. G., Corringham R., Blacklock H. A., Keaney M., Shannon M., Noone P., Gascoigne E., Fox J., Boesen E. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet. 1982 Apr 10;1(8276):826–829. doi: 10.1016/s0140-6736(82)91874-8. [DOI] [PubMed] [Google Scholar]
  7. Hay R. J., Clayton Y. M. The treatment of patients with chronic mucocutaneous candidosis and candida onychomycosis with ketoconazole. Clin Exp Dermatol. 1982 Mar;7(2):155–162. doi: 10.1111/j.1365-2230.1982.tb02403.x. [DOI] [PubMed] [Google Scholar]
  8. Heiberg J. K., Svejgaard E. Toxic hepatis during ketoconazole treatment. Br Med J (Clin Res Ed) 1981 Sep 26;283(6295):825–826. doi: 10.1136/bmj.283.6295.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hudson C. P., Callen J. P. Systemic blastomycosis treated with ketoconazole. Arch Dermatol. 1984 Apr;120(4):536–538. [PubMed] [Google Scholar]
  10. Lewis J. H., Zimmerman H. J., Benson G. D., Ishak K. G. Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology. 1984 Mar;86(3):503–513. [PubMed] [Google Scholar]
  11. Mahgoub E. S., Gumaa S. A. Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii. Trans R Soc Trop Med Hyg. 1984;78(3):376–379. doi: 10.1016/0035-9203(84)90126-3. [DOI] [PubMed] [Google Scholar]
  12. Robertson M. H., Rich P., Parker F., Hanifin J. M. Ketoconazole in griseofulvin-resistant dermatophytosis. J Am Acad Dermatol. 1982 Feb;6(2):224–229. doi: 10.1016/s0190-9622(82)70015-5. [DOI] [PubMed] [Google Scholar]
  13. Zaias N., Drachman D. A method for the determination of drug effectiveness in onychomycosis. Trials with ketoconazole and griseofulvin ultramicrosize. J Am Acad Dermatol. 1983 Dec;9(6):912–919. doi: 10.1016/s0190-9622(83)70208-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES